Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Feb 12, 2018 11:06am
232 Views
Post# 27544447

RE:RE:RE:RE:RE:Imagine Land!!!!

RE:RE:RE:RE:RE:Imagine Land!!!!Lol, lol, lol, Cmon u guys, how many u want at the luau, frostie, maniplulators, private equity funds, BANKSTERS, AND ANY OTHER SCUMBAG INVESTOR WILLING TO FEED????  man the trough just gets longer, WITH U SCUMBAGS, yaz!!! 
One nr brings just one pharma on board with a boatload of money, influence, credibility,  assistance, certitude, faster to market, more lives saved, sooner!!!
Now , remind us again what a pp does??? Here comes Roger mode, SILENCE!!! 


bionicjoe wrote: I'm not saying its a viable option without further investigation but private equity funds may be an avenue to explore. They can do a lot to help a financially strapped company grow.

https://www.blackstone.com/the-firm/asset-management/private-equity


Our investments span a wide range of industries around the world in established and growth-oriented businesses alike. Playing a vital role in helping companies realize their growth potential, we uncover value by identifying great companies and enhancing their performance by providing patient capital and operating support to strong management teams. Our approach helps our portfolio companies grow core businesses, launch new initiatives, make transformative acquisitions and upgrade technologies and systems to support their long-term strategy. 

We provide more than just capital. We seek to make the companies we invest in stronger through a bottoms-up strategy of transformation. Crucially, we bring the expertise of our Portfolio Operations Group to provide strategic guidance on a variety of operational improvements, including revenue growth, procurement, leadership development, lean process and IT optimization, energy sustainability, and employee health care.


Bullboard Posts